Zydus won final FDA approval to market a generic version of Vumerity for adults with relapsing forms of MS and active SPMS.
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback